Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 10/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.44 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1259945 | 0.84 | PARP10 (0.62) | PARP10FFAR1FFAR4IDO1ALDH1A1 | |
| SCHEMBL15080038 | 0.84 | CYP1A2 (0.49) | PARP10FFAR1FFAR4IDO1NPC1 | |
| SCHEMBL8846366 | 0.81 | PARP10 (0.59) | PARP10FFAR1FFAR4IDO1ALDH1A1 | |
| SCHEMBL2291386 | 0.81 | PARP10 (0.59) | PARP10FFAR1FFAR4IDO1ALDH1A1 | |
| SCHEMBL12423201 | 0.81 | MAOB (0.69) | PARP10IDO1ALDH1A1MAOBNPC1 | |
| SCHEMBL2293600 | 0.79 | FFAR4 (0.60) | PARP10FFAR1FFAR4IDO1ALDH1A1 | |
| SCHEMBL18171756 | 0.78 | ALDH1A1 (0.66) | PARP10FFAR1FFAR4IDO1ALDH1A1 | |
| SCHEMBL10465970 | 0.78 | FFAR1 (0.51) | PARP10FFAR1FFAR4ALDH1A1MAOB | |
| SCHEMBL2287943 | 0.78 | ALDH1A1 (0.57) | PARP10IDO1ALDH1A1NPC1RAB9A | |
| SCHEMBL5606933 | 0.77 | PARP10 (0.55) | PARP10FFAR1FFAR4IDO1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101679172-B | Method for producing benzaldehyde compound | SUMITOMO CO LTD | 2013-05-29 | — | — | CN | disclosed |
| US-7994367-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| CN-101679172-A | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL CO | 2010-03-24 | — | — | CN | disclosed |
| EP-2149545-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, C9, TRPA1 | PARP10 167/4885FFAR1 3643/4885FFAR4 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.